Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
Novartis
Novartis
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Thomas Jefferson University
Takeda
H. Lee Moffitt Cancer Center and Research Institute
Penn State University
City of Hope Medical Center
Celgene
Dana-Farber Cancer Institute
Incyte Corporation
NextCure, Inc.